Two Top Stories of NYSE: Fortive Corporation (NYSE:FTV), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Fortive Corporation (NYSE:FTV)

The shares of Fortive Corporation (NYSE:FTV) started off the last trading session with the price of $78.02 while closing the day with the price of $78.23. The shares of Fortive Corporation (NYSE:FTV) Rise 0.17% with the Gain of 0.21 points.

The shares of Fortive Corporation (NYSE:FTV) traded with the day volume of 2.02 Million shares whereas its average trading volume is 1.57 Million.

While analyzing the past performance of the stock we can see that the shares of Fortive Corporation (NYSE:FTV) Loss -2.54% in the last week while rising 5.45% in the last month. Past quarter performance shows the green light with 8.04%. The semi-annual and annual performance shows 13.07% and 31.46% respectively.

Some critical values of the shares of Fortive Corporation (NYSE:FTV) to be discussed here are: the beta which shows the value at 0 while Average True Range of Fortive Corporation (NYSE:FTV) demonstrate the value at 1.78. The weekly and monthly volatility of the shares of Fortive Corporation (NYSE:FTV) are indicated at 1.84% and 2.01%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 57.55.

While studying the financial position of the shares of Fortive Corporation (NYSE:FTV), we can see that the Market capitalization of the company is at 27.18 Billion. The shares outstanding for the company is 347.45 Million and the shares float stands at 307.02 Million. The income of the company stand at 974.5 Million while the sales stand at 6.66 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.76, Price to Earnings or P/E is at 28.31, Price to Sales P/S show the value of 4.08, the Return on Asset ROA stood at 0.114 and the Return on Equity ROE depicted at 0.314 while Return on Investment ROI is at 0.135.


ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) started its previous trading session at $25.17 and closed at $25.75 showing a Rise of 2.14 Percent.

The Company traded with an average Volume of 2.04 Million whereas, its Day Volume stood at 2.02 Million.

Looking at the performance of the stock, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Gain 1.66% in the last week in its shares price and -15.85% in the last month. Quarterly performance shows a red of -13.99 Percent while Semi-Annual and Annual performances shows a -29.16 and -31.33 percent respectively.

Beta for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at 3.43 while the ATR (average true range) is at 1.3. The Stock’s Weekly and Monthly Volatility is 3.24% and 4.55% respectively showing a RSI value of 44.53.

While studying the financial position of the shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), we can see that the Market capitalization of the company is at 3.14 Billion. The shares outstanding for the company is 122.09 Million and the shares float stands at 122.09 Million.

The Company generated an income of -220500000 and the sales of 124.9 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.81 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 25.17 respectively.

The Return on Assets stands at -0.659, ROE shows a value of -0.73 and ROI for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is -0.67 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment